Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Interest Expenses of $6.1 million for Q1 2026, down 76.48% year-over-year from $26.1 million in Q1 2025, and down 25.24% quarter-over-quarter from $8.2 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 76.48% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $37.6 million (up 43.78% YoY), while the FY2025 annual figure was $34.5 million, down 95.03% from the prior year.
- Interest Expenses for Q1 2026 stood at $6.1 million, down from $8.2 million in the prior quarter.
- The five-year high for Interest Expenses was $26.2 million in Q3 2025, with the low at $6.1 million in Q1 2026.
- The 5-year median for Interest Expenses is $24.4 million (2022), against an average of $19.3 million.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses jumped 119.59% in 2025, then sank 76.48% in 2026.
- Maravai Lifesciences Holdings' Interest Expenses stood at $8.8 million in 2022, then surged by 56.73% to $13.8 million in 2023, then declined by 18.17% to $11.3 million in 2024, then decreased by 27.01% to $8.2 million in 2025, then decreased by 25.24% to $6.1 million in 2026.
- Business Quant data shows MRVI's Interest Expenses at $6.1 million in Q1 2026, $8.2 million in Q4 2025, and $26.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 4.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.81 Mn |
| Jun 30, 2026 | 4.81 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 8.22 Mn |
| Dec 31, 2025 | 8.22 Mn |
| Sep 30, 2025 | 26.22 Mn |
| Sep 30, 2025 | 26.22 Mn |
| Jun 30, 2025 | 26.22 Mn |
| Jun 30, 2025 | 26.22 Mn |
| Mar 31, 2025 | 26.13 Mn |
| Mar 31, 2025 | 26.13 Mn |
| Dec 31, 2024 | 11.26 Mn |
| Dec 31, 2024 | 11.26 Mn |
| Sep 30, 2024 | 25.99 Mn |
| Sep 30, 2024 | 25.99 Mn |
| Jun 30, 2024 | 11.94 Mn |
| Jun 30, 2024 | 11.94 Mn |
| Mar 31, 2024 | 12.14 Mn |
| Mar 31, 2024 | 12.14 Mn |